This trial is active, not recruiting.

Condition mesenteric ischemia
Sponsor Saarland University
Start date January 2008
End date December 2014
Trial size 10000 participants
Trial identifier NCT02901808, 209/15


The registry includes patients undergoing cardiovascular and thoracic surgery at the Saarland University Medical Center, Homburg/Saar, Germany. This study is a monocentric, retrospective study investigating the development of NOMI and outcome of patients.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective
Patients suffering from NOMI
Patients not suffering from NOMI

Primary Outcomes

Development of NOMI
time frame: at the day of surgery, day zero

Secondary Outcomes

Lenght of stay
time frame: at the day of surgery, day zero up to 365 days
Mechanical ventilation
time frame: at the day of surgery, day zero up to 365 days
time frame: at the day of surgery, day zero up to 365 days

Eligibility Criteria

Male or female participants up to 100 years old.

Inclusion Criteria: - The investigators include anonymous data from patients with cardio-thoracic surgery Exclusion Criteria:

Additional Information

Official title Interdisciplinary Retrospective Registeranalysis for the Examination of Non-occlusive Mesenteric Ischemia (NOMI)
Description All data were acquired from the hospital electronic health record and the picture archiving computer system (PACS). NOMI was suspected if the following clinical signs occured: new onset of oliguria (urine output <0.5 mL/kg/hour for at least 6 hours) or anuria, abdominal distention with decreased or absent bowel sounds, elevated serum lactate levels >5.0mmol/L or metabolic acidosis (base excess <-5mmol/L). In accordance to the definition of cardiogenic shock angiography was performed in patients with a systolic blood pressure >90 mmHg and a cardiac index >1.8 L/minute/m².
Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by Saarland University.